Search results

From WikiMD's Food, Medicine & Wellness Encyclopedia

Page title matches

Page text matches

  • ...] (CKD), [[cancer]] chemotherapy, and [[HIV/AIDS]] treatment. ESAs work by stimulating the [[bone marrow]] to produce more [[red blood cells]], thereby increasing ...stering ESAs, the erythropoietin levels in the body are increased, thereby stimulating the bone marrow to produce more red blood cells.
    2 KB (333 words) - 13:15, 24 March 2024
  • ===Erythropoiesis-Stimulating Agents (ESAs)=== ...ed with chronic kidney disease, cancer, and other chronic illnesses. These agents work by mimicking the action of [[erythropoietin]], a hormone produced by t
    3 KB (417 words) - 03:08, 2 April 2024
  • ...le:Erythropoietin.png|Erythropoietin|thumb]] '''Erythropoiesis-stimulating agents''' ('''ESAs''') are [[biopharmaceutical]]s that stimulate the production of ...n and maturation into functional red blood cells. This process, known as [[erythropoiesis]], helps to increase the oxygen-carrying capacity of the blood, alleviating
    3 KB (436 words) - 02:11, 24 April 2024
  • ...various [[gene]]s that are regulated by HIF, including those involved in [[erythropoiesis]], [[angiogenesis]], and [[metabolism]]. ...imulate erythropoiesis, potentially reducing the need for [[erythropoiesis-stimulating agent]]s. In cancer, they may be able to inhibit tumor growth by blocking a
    2 KB (240 words) - 19:04, 8 March 2024
  • ===Erythropoiesis-Stimulating Agents (ESAs)=== ...c kidney disease, chemotherapy, and certain chronic diseases. They work by stimulating the bone marrow to produce more red blood cells. Examples include [[epoetin
    3 KB (417 words) - 04:23, 22 March 2024
  • ...nd peginesatide are collectively referred to as erythropoiesis-stimulating agents (ESA). Dosages and dose regimens (daily, three times weekly, weekly, and e {{hematologic agents}}
    1 KB (137 words) - 13:51, 8 May 2019
  • ...the presence of normal oxygen levels, thereby promoting EPO production and stimulating the production of red blood cells. ...ents, its effectiveness compared to traditional erythropoiesis-stimulating agents (ESAs), and its safety profile. The results of these trials have been pivot
    3 KB (469 words) - 07:30, 22 March 2024
  • ...tinguishing it from traditional treatments like erythropoiesis-stimulating agents. * Treatment of anemia failing an erythropoiesis stimulating agent and requiring 2 or more RBC transfusions over 8 weeks in adult patien
    3 KB (380 words) - 10:22, 22 March 2024
  • ...nd peginesatide are collectively referred to as erythropoiesis-stimulating agents (ESA). Dosages and dose regimens (daily, three times weekly, weekly, and e {{hematologic agents}}
    1 KB (197 words) - 13:50, 8 May 2019
  • ...amily, specifically those involved in the signaling pathways that regulate erythropoiesis and angiogenesis. By modulating these pathways, Sotatercept can promote red ...uld provide an effective alternative to current erythropoiesis-stimulating agents, with the potential for fewer side effects.
    3 KB (447 words) - 11:00, 22 March 2024
  • * [[Enzyme Inhibitors]]  (1444) • Compounds or agents that combine with an enzyme in such a manner as to prevent the normal subst * [[Erythropoiesis Stimulating Agents]]  (0) see [[Hematinics]]
    2 KB (262 words) - 00:38, 5 April 2019
  • ...e to inflammation or infection, leading to alterations in iron metabolism, erythropoiesis (the production of red blood cells), and the lifespan of red blood cells. ...inhibiting iron release. This results in reduced availability of iron for erythropoiesis, despite normal or increased iron stores in the body.
    3 KB (428 words) - 23:35, 26 March 2024
  • ...types of [[stroke]]. Examples include [[warfarin]], [[heparin]], and newer agents like [[apixaban]] and [[rivaroxaban]]. ===Antianemic Agents===
    4 KB (505 words) - 06:48, 31 March 2024
  • * [[Erythropoiesis-stimulating agents]]: These medications stimulate the body to produce more red blood cells.
    2 KB (264 words) - 18:45, 25 February 2024
  • * [[Erythropoiesis-stimulating agents]]: These medications stimulate the body to produce more red blood cells.
    2 KB (264 words) - 17:46, 25 February 2024
  • ...ALI]]). To minimize these risks, blood is rigorously tested for infectious agents, and transfusion protocols are strictly followed. ...atives to PRBC transfusion include the use of [[erythropoiesis-stimulating agents]] (ESAs) to stimulate red blood cell production, [[iron therapy]] for iron-
    3 KB (457 words) - 03:31, 30 March 2024
  • ...ing agents (ESAs). However, roxadustat offers a novel approach by directly stimulating the body's own EPO production. Clinical trials have demonstrated the effica
    3 KB (448 words) - 07:57, 22 March 2024
  • ...ndition. In severe cases, blood transfusions or erythropoiesis-stimulating agents may be necessary.
    2 KB (339 words) - 00:59, 31 March 2024
  • ...tments for anemia, such as iron supplements and erythropoiesis-stimulating agents, are generally considered to be more effective and have fewer side effects.
    2 KB (341 words) - 14:03, 3 March 2024
  • ...th improved hemoglobin levels, reduced need for erythropoiesis-stimulating agents (ESAs), and a lower incidence of iron overload.
    3 KB (426 words) - 23:25, 6 April 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)